INVO Fertility Inc

Finanzen von INVO Fertility Inc (NAYA)

$2.200

+0.184 (+8.37%)Zum Schluss

Profitabilität und Margen von NAYA

Evaluating the bottom line, NAYA Biosciences Inc maintains a gross margin of 14.95%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -90.74%, while the net margin is -113.78%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively NAYA converts its operational activities into shareholder value.

NAYA im Vergleich zur Peergroup

In the context of the broader market, NAYA competes directly with industry leaders such as OTRK and MNDR. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, NAYA's gross margin of 14.95% stands against OTRK's 36.99% and MNDR's 16.94%. Such benchmarking helps identify whether NAYA Biosciences Inc is trading at a premium or discount relative to its financial performance.

Financials

FY2024Q3
YoY:
+47.01%
1.43M
Total Revenue
FY2024Q3
YoY:
+46.72%
-1.30M
Operating Profit
FY2024Q3
YoY:
+30.62%
-1.63M
Net Income after Tax
FY2024Q3
YoY:
-40.00%
-0.42
EPS - Diluted
FY2024Q3
YoY:
-52.73%
-640.81K
Free Cash Flow
FY2024Q3
YoY:
-60.97%
14.95
Gross Profit Margin - %
FY2024Q3
YoY:
-81.51%
-52.21
FCF Margin - %
FY2024Q3
YoY:
-11.15%
-113.78
Net Margin - %

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten